Retireful LLC Trims Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Retireful LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,750 shares of the medical equipment provider’s stock after selling 612 shares during the quarter. Intuitive Surgical accounts for 0.6% of Retireful LLC’s investment portfolio, making the stock its 28th largest position. Retireful LLC’s holdings in Intuitive Surgical were worth $860,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the period. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth about $26,000. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. LRI Investments LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at about $30,000. Finally, LGT Financial Advisors LLC grew its position in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $538.82 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $544.38. The stock has a market capitalization of $191.92 billion, a PE ratio of 86.63, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The business has a 50 day simple moving average of $501.42 and a 200-day simple moving average of $460.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $524.61.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the transaction, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.